Literature DB >> 20210566

Continuous glucose monitoring reveals associations of glucose levels with QT interval length.

T Kubiak1, A Wittig, C Koll, B Mraz, J Gustav, U Herrmann, H Weber, W Kerner.   

Abstract

BACKGROUND: QTc interval lengthening during hypoglycemia is discussed as a mechanism linked to sudden death in diabetes patients and the so-called "dead in bed syndrome." Previous research reported a high interindividual variability in the glucose-QTc association. The present study aimed at deriving parameters for direction and strength of the glucose-QTc association on the patient level using combined Holter electrocardiogram (ECG) and continuous glucose monitoring.
METHODS: Twenty type 1 diabetes patients were studied: mean (SD, range) age, 43.6 (10.8, 22-65) years; gender male (n [%]), 10 (50.0%); mean (SD) hemoglobin A1C, 8.5% (1.0%); and impaired hypoglycemia awareness (n [%]), six (30.0%). Continuous interstitial glucose monitoring and Holter ECG monitoring were performed for 48 h. Hierarchical (mixed) regression modeling was used to account for the structure of the data.
RESULTS: Glucose levels during nighttime were negatively associated with QTc interval length if the data structure was accounted for (b [SE] = -0.76 [0.17], P = 0.000). Exploratory regression analysis revealed hypoglycemia awareness as the only predictor of the individual strength of the glucose-QTc association, with the impaired awareness group showing less evidence for an association of low glucose with QTc lengthening.
CONCLUSIONS: Mixed regression allows for deriving parameters for the glucose-QTc association on the patient level. Consistent with previous studies, we found a large interindividual variability in the glucose-QTc association. The finding on impaired hypoglycemia awareness patients has to be interpreted with caution but provides some support for the role of sympathetic activation for the QTc-glucose link.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20210566     DOI: 10.1089/dia.2009.0153

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  7 in total

1.  Severe Hypoglycemia and Incidence of QT Interval Prolongation Among Adults With Type 2 Diabetes.

Authors:  Arnaud D Kaze; Matthew F Yuyun; Sebhat Erqou; Gregg C Fonarow; Justin B Echouffo-Tcheugui
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

Review 2.  The ECG vertigo in diabetes and cardiac autonomic neuropathy.

Authors:  Christina Voulgari; Nicholas Tentolouris; Christodoulos Stefanadis
Journal:  Exp Diabetes Res       Date:  2011-05-29

3.  Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation.

Authors:  Candace M Reno; Dorit Daphna-Iken; Y Stefanie Chen; Jennifer VanderWeele; Krishan Jethi; Simon J Fisher
Journal:  Diabetes       Date:  2013-07-08       Impact factor: 9.461

4.  Inter-individual variability and modeling of electrical activity: a possible new approach to explore cardiac safety?

Authors:  Jean-Yves Le Guennec; Jérôme Thireau; Aude Ouillé; Julien Roussel; Jérôme Roy; Serge Richard; Sylvain Richard; Eric Martel; Pascal Champéroux
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

5.  Does hair dye use really increase the risk of prostate cancer?

Authors:  Bang-Ping Jiann
Journal:  BMC Cancer       Date:  2017-11-07       Impact factor: 4.430

6.  Metabolomic patterns associated to QTc interval in shiftworkers: an explorative analysis.

Authors:  Marcello Campagna; Emanuela Locci; Roberto Piras; Antonio Noto; Luigi Isaia Lecca; Ilaria Pilia; Pierluigi Cocco; Ernesto d'Aloja; Paola Scano
Journal:  Biomarkers       Date:  2016-04-28       Impact factor: 2.658

7.  Changes in Serum Electrolytes, ECG, and Baroreflex Sensitivity during Combined Pituitary Stimulation Test.

Authors:  Sungsu Kim; Choong Hwan Kwak; Jaehoon Jung; Jong Ha Baek; Jung Hwa Jung; Ki-Jong Park; Kyongyoung Kim; Soo Kyoung Kim; Dawon Kang; Jong Ryeal Hahm
Journal:  Biomed Res Int       Date:  2018-05-09       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.